Jong-Mook Kim

Title: Innovations of Jong-Mook Kim in Recombinant Cell Line Selection

Introduction

Jong-Mook Kim is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of methods for selecting high expression recombinant cell lines. His work has implications for more efficient protein production, which is crucial in various biopharmaceutical applications.

Latest Patents

Jong-Mook Kim holds 2 patents that showcase his innovative approaches. One of his latest patents is a method for selecting a high expression recombinant cell line. This invention relates to a method of selecting high producer clones by using an expression vector. The expression vector comprises a gene expression cassette with a selectable marker gene linked to polyA and another gene expression cassette encoding a recombinant protein of interest. This method allows for the selection of high producer clones from cell populations at least 10 times fewer than existing methods. It also enables the use of a low concentration of MTX, reducing the development period of cell lines and the associated labor and costs.

Another significant patent by Kim is an expression vector for animal cells that includes at least one copy of MAR DNA sequences at the 3' terminal of the transcription termination region of a gene. This vector is designed to facilitate the expression of foreign genes, providing a robust tool for genetic engineering in animal cells.

Career Highlights

Jong-Mook Kim is currently employed at Celltrion Inc., a leading biopharmaceutical company. His work at Celltrion has allowed him to apply his innovative methods in a practical setting, contributing to advancements in the production of therapeutic proteins.

Collaborations

Throughout his career, Jong-Mook Kim has collaborated with notable colleagues, including Bok-hwan Chun and Myung-sam Cho. These collaborations have further enhanced his research and development efforts in the field of biotechnology.

Conclusion

Jong-Mook Kim's contributions to the field of biotechnology, particularly in the selection of high expression recombinant cell lines, demonstrate his innovative spirit and commitment to advancing protein production methods. His patents reflect a significant step forward in biopharmaceutical technology, paving the way for more efficient and cost-effective solutions in the industry.